-
-
Review of Efficacy of Ginkgo; Celebrex OK for Asthma Patients; Losartan Not Superior to Captopril; Alfa-Interferon Could Help Fight West Nile; FDA Actions
-
This invited article reviewing schistosomiasis in travelers describes the pertinent features of this disease as it presents in the nonimmune tourist.
-
Careful evaluation of epidemiologic data from recent African outbreaks of meningococcal disease suggests that significant risks now extend beyond the sub-Saharan belt through the Rift Valley and Great Lakes regions into Mozambique, then into Namibia and Angola.
-
Review of Efficacy of Ginkgo; Celebrex OK for Asthma Patients; Losartan Not Superior to Captopril; Alfa-Interferon Could Help Fight West Nile; FDA Actions
-
-
A randomized controlled trial in Australia showed that a 16 week program of tai chi reduced falls by 33% in a group of elderly persons.
-
Two hundred eighty-eight patients hospitalized with severe community-acquired pneumonia (CAP) were followed for 28 days in a prospective multicenter study. At day 7, 25% of patients had resolution of CXR abnormalities and 56% had improvement. At day 28, 53% of patients had resolution of CXR abnormalities and 78% had clinical cure. By multivariate analysis, delayed resolution of CXR abnormalities by day 7 was associated with multilobar disease, dullness to percussion by physical exam, elevated CRP (> 200 mg/L), and tachypnea (respiratory rate > 25/min.) on admission.
-
Asymptomatic brain MRI findings of infarct, cerebral aneurysms and benign tumors were fairly common in the general population. The clinical significance of these findings is unknown.
-
The FDA has approved a new drug for the treatment of advanced breast cancer.